Andrew Koff, PhD

Lab Head

Andrew Koff, PhD

Lab Head

Share
Print
Share
Print
Andrew Koff, PhD

Office Phone

212-639-2354

Office Fax

646-422-2062

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Andrew Koff discloses the following relationships and financial interests:

  • Atropos Therapeutics, Inc.
    Ownership / Equity Interests; Provision of Services
  • Concarlo Holdings, LLC
    Provision of Services
  • Eli Lilly and Company
    Provision of Services (uncompensated)
  • PTT Global Chemical PLC and GC Ventures
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures